Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.

Title Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.
Authors Choi WR1, Roh JL2, Gong G3, Cho KJ3, Choi SH1, Nam SY1, Kim SY1
Affiliation 1. Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

2. Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: rohjl@amc.seoul.kr.

3. Departments of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Journal Oral Oncology 2019 Jul;94:106-110.
content
(³»¿ë ¿ä¾à)
°©»ó¼± À¯µÎ¾ÏÀÇ ´Ù¹ß¼º ¶Ç´Â ¾çÃø¼ºÀÌ Àç¹ßÀÇ À§ÇèÀ» Áõ°¡½ÃÅ°´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸³ª, ÀÓ»óÀû ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâÀº ³í¶õÀÌ µÇ°í ÀÖ¾î º» ¿¬±¸¿¡¼­´Â À¯µÎ¾ÏÀÇ ´Ù¹ß¼º ¶Ç´Â ¾çÃø¼ºÀÌ Àü°©»ó¼±ÀýÁ¦¼ú ÀÌÈÄ Àç¹ß°ú »ýÁ¸·ü¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æò°¡ÇÏ¿´´Ù.

°©»ó¼±ÀüÀýÁ¦¼úÀ» ½ÃÇàÇÏ°í, À¯µÎ¾ÏÀ¸·Î º´¸®ÇÐÀûÀ¸·Î Áø´Ü¹ÞÀº 2390¸íÀÇ È¯ÀÚ¸¦ ÈÄÇâÀûÀ¸·Î ºÐ¼®ÇÏ¿´´Ù. ´Ù¹ß¼º ¶Ç´Â ¾çÃø¼ºÀº ¼ö¼ú ÈÄ ÀûÃâµÈ Á¶Á÷¿¡¼­ º´¸®ÇÐÀûÀ¸·Î È®ÀÎÇÏ¿© °áÁ¤ÇÏ¿´´Ù.

´Ù¹ß¼ºÀº 37.3% ȯÀÚ¿¡¼­ È®ÀεǾú°í, ¾çÃø¼ºÀº 24.8%¿¡¼­ È®ÀεǾú´Ù. ´Ùº¯·® ºÐ¼®¿¡¼­ ´Ù¹ß¼º, ¸²ÇÁÇ÷°üħ¹ü, Nº´±â, ÀüÀÌµÈ ¸²ÇÁÀý°³¼ö (>5)°¡ ÀÖÀ» ¶§ Åë°èÀûÀ¸·Î À¯ÀÇÇÏ°Ô Àç¹ßÀÌ Áõ°¡ÇÏ´Â °ÍÀ» È®ÀÎÇÏ¿´´Ù. À¯µÎ¾ÏÀÇ ´Ù¹ß¼ºÀÇ Recurrence-free survival¿¡ ´ëÇÑ Adjusted hazard ratio´Â 1.93 (95% confidence interval=1.33-2.80; P = 0.001) À̾ú´Ù. 1cm¸¦ ±âÁØÀ¸·Î À¯µÎ¾ÏÀÇ Å©±â¸¦ ³ª´©¾î¼­ ºÐ¼®Çغ¸¾ÒÀ» ¶§, ¹Ì¼¼À¯µÎ¾Ï¿¡¼­´Â ´Ù¹ß¼ºÀÌ Àç¹ß¿¡ À¯ÀÇÇÏÁö ¾Ê¾ÒÀ¸³ª, 1cm ÃÊ°úÀÎ °æ¿ì ƯÈ÷ À¯ÀÇÇÏ°Ô ´Ù¹ß¼ºÀÌ Àִ ȯÀÚ¿¡¼­ Àç¹ßÀÌ ¸¹¾Ò´Ù.
Clinical
importance
°©»ó¼± À¯µÎ¾ÏÀÇ ´Ù¹ß¼ºÀÌ ¼ö¼ú Àü¿¡ ¼ö¼ú¹üÀ§¸¦ °áÁ¤Çϴµ¥ À־ ¿µÇâÀ» ÁÙ ¼ö ÀÖÁö¸¸, ¿¹ÈÄ¿ÍÀÇ °ü·Ã¼º ¹× ±×¿¡ µû¸¥ ¼ö¼ú ÈÄ Ãß°¡Ä¡·á °áÁ¤¿¡ ¹ÌÄ¡´Â ¿µÇâ¿¡ ´ëÇؼ­´Â ³í¶õÀÌ µÇ°í Àִµ¥, º» ¿¬±¸¸¦ ÅëÇØ ¼ö¼ú ÈÄ º´¸®ÇÐÀûÀ¸·Î È®ÀÎµÈ ´Ù¹ß¼º ¶Ç´Â ¾çÃø¼º ¶ÇÇÑ risk stratification¿¡¼­ °í·ÁÇØ¾ß ÇÑ´Ù°í °á·ÐÀ» Áö¾ú´Ù. º» ¿¬±¸´Â ´ÜÀÏ ±â°ü¿¡¼­ 2300¿©¸íÀÇ ¸ðµç ȯÀÚ¿¡ ´ëÇÏ¿© Total thyroidectomy ¿Í central neck dissection (CND) ÀÌ»óÀ» ½ÃÇàÇÏ¿´°í, 90%ÀÇ È¯ÀÚ¿¡¼­ RAI¸¦ ½ÃÇàÇÏ¿´±â ¶§¹®¿¡ Ä¡·á¸é¿¡¼­ ºñ±³Àû ±ÕÁúÇÑ cohort ¿¡¼­ ¾òÀº °á°ú¶ó°í ÇÒ ¼ö ÀÖ¾î ÀÓ»óÀû Àǹ̰¡ ÀÖÀ¸³ª, retrospective studyÀÇ ÇÑ°è, ÃÖ±Ù ATA guideline¿¡¼­ routineÇÑ CND ¹× RAI¸¦ ±ÇÀ¯ÇÏ°í ÀÖÁö ¾ÊÀ¸¸ç, subgroup analysis ¿¡¼­µµ È®ÀÎÇÒ ¼ö ÀÖµíÀÌ À¯ÀÇÇÏÁö ¾Ê¾Ò´ø, microcarcinoma°¡ °¢ group ¿¡¼­ 50%ÀÌ»ó Æ÷ÇԵǾî ÀÖ´Ù´Â Á¡¿¡¼­ ÇÑ°è°¡ ÀÖ¾î, ±× °á°úÀÇ Çؼ®¿¡ ÁÖÀǸ¦ ¿äÇÑ´Ù.

Ãæ³²´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú ÀåÀç¿ø